Develops customizable nanowire biosensor platforms that enable ultra-sensitive detection of low-abundance biomolecules, improving diagnostic accuracy for diseases. These platforms support next-generation DNA sequencing and molecular biomarker identification, offering up to 8X more genetic information in reduced time and cost compared to current methods.

Cascade Drives designs and manufactures electromechanical drives, including the TruEPS™ electric power steering system and heavy-duty linear actuators, for heavy-duty vehicles and industrial applications. These solutions replace hydraulic systems, providing enhanced efficiency, precision, and resilience against shock loads, thereby improving operational productivity and reducing maintenance costs.

Developeration AB is developing PexyEazy®, a surgical device for hemorrhoid treatment that enables procedures without general anesthesia and completes them in under 10 minutes. This technology significantly reduces postoperative pain and lowers treatment costs by up to 70%, addressing the need for more efficient and less invasive surgical options.

Nanolyze offers instruments for real-time analysis of single nanoparticles and bulk material characterization. Their technology enables researchers to study the properties and behavior of nanoparticles with high precision.

Stockholm Water Technology utilizes patented electro-capacitive technology to remove charged contaminants from water without chemicals or membranes, making it effective for heavy metal purification and nutrient reduction. Their systems operate autonomously with remote monitoring, reducing maintenance costs while ensuring compliance with water quality standards for industries and municipalities.

UmanSense AB has developed Stroke Alarm, a mobile solution that continuously monitors arm movements to detect potential stroke symptoms. The system alerts pre-selected contacts, ensuring timely intervention for patients who may otherwise receive treatment too late.

Vakona develops an antibiotic-free treatment for inflammatory acne using a natural bacterial enzyme that degrades bacterial biofilm. This approach targets the root cause of acne by effectively disrupting the biofilm formation that contributes to inflammation and infection.

VOC Diagnostics utilizes a unique method of analyzing volatile organic compounds in blood plasma samples to detect ovarian cancer at an early stage with high sensitivity and specificity. This technology addresses the critical challenge of late-stage diagnosis in ovarian cancer, which significantly impacts treatment outcomes and survival rates.